The European project CARDIOPATCH (Network of Excellence for the development of Advanced Therapies of Myocardial Infarction treatment based on regenerative medicine and 3D printing), which aims to create a new treatment through regenerative medicine and 3D printing for patients who have suffered a myocardial infarction, has developed a digital platform to connect the key players of the biotechnology sector and the 3D printing technologies from Southwestern Europe.
Shutterstock
The characteristics and services of this interactive platform, which is integrated in its official website, will be presented on the 30 April at 4:00 PM in a virtual meeting via Zoom. The event is open to the public and the registrations can be made following this link.
During the webinar, the website of CARDIOPATCH project will be presented along with an explanation of its main services.
Specifically, the members of the project's consortium will explain the functioning of the funding opportunities search tool and the space dedicated to encourage synergies and collaborative projects.
A map of capacities will also be presented. This interactive environment allows the user to travel geographically through Southwestern Europe searching for research institutions and entities focused on the biomedical sector and 3D printing technologies, as well as research projects working in these fields.
All interested entities can join the network to discover how they can develop new collaborations and innovation projects.
Felipe Prósper, director of the Navarra University Clinic Cell Therapy Department and project chief scientific officer, will be in charge of the presentation.
Co-funded by the EU Interreg Sudoe Programme, via the European Regional Development Fund (ERDF), CARDIOPATCH is led by Clínica Universidad de Navarra.